tm logo
Live/Pending
NEW APPLICATION - ASSIGNED TO EXAMINER

assigned to examiner

on 16 Nov 2024

Last Applicant/ Owned by

Great Abington, Cambridge CB21 6GS

GB

Serial Number

79399473 filed on 02th May 2024

Registration Number

N/A

Correspondent Address

Andrew D. Price

Andrew D. Price Venable LLP

Washington, DC 20043-9998

United States

Filing Basis

1. filing basis filed as 66 a

Disclaimer

NO DATA

Logo Mark Trademark Information

Scientific and technological services and research and design relating thereto; industrial analysis and research services; pharmaceutical research and development services; medical research and development services; pharmaceutical testing and clinical trials; clinical trials; research and development in the field of oncology; research and development in the field of ophthalmology; research and dev Read More

Classification Information


Class [044]
Medical, Beauty & Agricultural Services


Medical services; medical testing; healthcare services; pharmaceutical services; medical consulting services; advisory services relating to pharmaceuticals; consultancy and information services relating to pharmaceuticals; medical services in the field of oncology; medical services in the field of ophthalmology; medical services in the field of neurology; medical services in the field of anti-infectives; medical services in connection with respiratory disease; medical services in connection with cardiovascular disease; medical services in connection with metabolic disease; medical services in connection with the treatment and/or prevention of viral infections; medical services in connection with diagnostics and imaging; medical services in connection with renal disease; medical services in connection with gastrointestinal disease; medical services in connection with muscular skeletal disease; pharmaceutical services in the field of oncology; pharmaceutical services in the field of ophthalmology; pharmaceutical services in the field of neurology; pharmaceutical services in the field of anti-infectives; pharmaceutical services in connection with respiratory disease; pharmaceutical services in connection with cardiovascular disease; pharmaceutical services in connection with metabolic disease; pharmaceutical services in connection with the treatment and/or prevention of viral infections; pharmaceutical services in connection with diagnostics and imaging; pharmaceutical services in connection with renal disease; pharmaceutical services in connection with gastrointestinal disease; pharmaceutical services in connection with muscular skeletal disease; information, consultancy and advisory services relating to the aforesaid.


First Use Date in General

N/A

First Use Date in Commerce

N/A

Class [042]
Computer & Software Services & Scientific Services


Scientific and technological services and research and design relating thereto; industrial analysis and research services; pharmaceutical research and development services; medical research and development services; pharmaceutical testing and clinical trials; clinical trials; research and development in the field of oncology; research and development in the field of ophthalmology; research and development in the field of neurology; research and development in the field of anti-infective pharmaceuticals; research and development in the field of respiratory disease; research and development in the field of cardiovascular disease; research and development in the field of metabolic disease; research and development in the field of antiviral drugs; research and development in the field of diagnostics and imaging; research and development in the field of renal disease; research and development in the field of gastrointestinal disease; research and development in the field of muscular skeletal disease; information consultancy and advisory services relating to the aforesaid.


First Use Date in General

N/A

First Use Date in Commerce

N/A

Class [005]
Pharmaceutical Products


Pharmaceuticals; pharmaceutical preparations; pharmaceutical products; pharmaceutical products and preparations for use in relation to oncology; pharmaceutical products and preparations for use in relation to ophthalmology; pharmaceutical products and preparations for use in relation to neurology; anti-infective pharmaceutical products and preparations; pharmaceutical products and preparations for the treatment and/or prevention of respiratory disease; pharmaceutical products and preparations for the treatment and/or prevention of cardiovascular disease; pharmaceutical products and preparations for the treatment and/or prevention of metabolic disease; pharmaceutical products and preparations for the treatment and/or prevention of viral infections; pharmaceutical products and preparations for use in diagnostics and imaging; pharmaceutical products and preparations for the treatment and/or prevention of renal disease; pharmaceutical products and preparations for the treatment and/or prevention of gastrointestinal disease; pharmaceutical products and preparations for the treatment and/or prevention of muscular skeletal disease.


First Use Date in General

N/A

First Use Date in Commerce

N/A

Mark Details


Serial Number

No 79399473

Mark Type

No Service Mark

Attorney Docket Number

No 599729

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

Yes

66A Current

Yes

Current Basis

No

No Basis

No

Design Code(s)

18.03.01 -

Bicycles, tricycles, unicycles

24.17.12 -

Infinity symbol

26.01.03 -

Incomplete circles (more than semi-circles)

26.01.13 -

Two circles

26.17.01 -

Straight line(s), band(s) or bar(s)

26.17.06 -

Diagonal line(s), band(s) or bar(s)

26.17.10 -

Zig-zag line(s)

Legal History


Status DateAction Taken
16th Nov 2024ASSIGNED TO EXAMINER
19th Sep 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
19th Sep 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
19th Sep 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
19th Sep 2024TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
19th Sep 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
12th Jul 2024APPLICATION FILING RECEIPT MAILED
12th Jul 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
11th Jul 2024SN ASSIGNED FOR SECT 66A APPL FROM IB